Farmanews.com

Notas de Prensa  

Farmacéutica. 20 de febrero de 2017
Cphi russia 2017

Russian Government drive to increase domestic manufacturing fuelling growth at CPhI Russia

Distributors, API manufacturers, and machinery providers seeing high demand across Russia and CIS

Amsterdam, 20th February 2017: CPhI Russia @IPhEB (#cphirussia) returns to the Russian capital – taking place at the JSC VDNH (VVC), Moscow 28th-30th March – as the Government’s Pharma 2020 plan continues to stimulate demand for international pharmaceutical ingredients, manufacturing and packaging equipment. The event’s 4th edition will see the P-MEC zone – for pharma machinery specialists - and the Innopack zone – for pharma packaging professionals; and feature a three-day trade show, the content-led IPhEB Conference (Forum) and numerous networking opportunities.

 

Collectively, the partnerships and deals struck at CPhI Russia have helped establish Russia at the forefront of pharmerging markets and it is expected to reach a value of $31.2 billion by 2019. This, coupled with a Government commitment to invest nearly $5 billion in funding to bring existing manufacturing sites to GMP standards, is driving increased interest in the event. Under the new plan, foreign investment is also encouraged through a fast-track approval process and tax incentives.

 

The country has attracted a strong base of international pharma companies – an overwhelming 76% of total pharmaceutical sales are attributed to imported drugs – with many more foreign manufacturers now looking to capitalise on this attractive market. Integral to the internationalisation of this market is CPhI Russia, which acts a central hub for buyers and sellers within the region, providing a vital platform where pharma executives can connect, build and nurture existing relationships. With a limited API manufacturing base, the country also presents strong partnership and supply opportunities for manufacturers from China and India.

 

“We are seeing a steady growth in three main areas driven by a gentrifying healthcare sector, a rising local population and government support for domestic manufacturing. Currency variation aside, the pharma market is growing at just under 10% year-on-year and distributers, APIs manufacturers and machinery providers are seeing high demand across Russia and CIS countries. Traditionally, Russia has been a hard market to enter and that is why CPhI Russia has become so intertwined with the market’s growth.” Commented Orhan Caglayan, Brand Director at CPhI Russia.

 

The event will gather more than 3000 attendees from 64 countries, and 199 exhibitors to network and do business with the top pharma ingredients, manufacturers, packaging experts, and machining specialists in the region. Attendees are able to gain in-depth insights from the International Forum, a dedicated matchmaking program, speaker sessions, and other networking opportunities. The programme includes detailed analysis on ‘Compulsory licensing: features, opportunities and threats’, ‘Drugs labelling: first experience and prospects’, ‘Modern assortment solutions and global trends in the pharmaceutical packaging industry’. As well as a session that explores the dramatic rise in new machinery and the move towards increased GM standards – entitled ‘Russian inspectorate does not sleep. Latest news about GMP’.

 

“The Russia pharma market has yet to reach its full potential and by bringing together regional companies with C-level executives, we hope to speed its development. The unique content and market analysis at the event are essential in helping both domestic and international companies evaluate best opportunities for partnerships and growth”, added Caglayan.

 

At CPhI Russia partnerships are created with leading companies and government institutions from Russia, CIS, and CEE regions. To speed-up and tailor each companies visit, the CPhI Russia pharma matchmaking service allows attendees to schedule meetings with only the most relevant partners – its also enables sellers to becomes buyers as they see new potential suppliers.

 

Tatyana Andreeva, the Project Manager of Codema – a company that created a platform for qualified persons, auditors and consultants to exchange ideas on API related topics – said, “At CPhI Russia, you can seize the opportunity to find partners to work with in Russia. Without this kind of event it is extremely difficult to approach the Russian market.”

 

For more information please visit: http://www.cphi.com/russia    

 

 

 

About CPhI

CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, North America, Korea, China, India, Japan, Southeast Asia, Istanbul and Russia, and co-locates with ICSE for contract services, P-MEC for machinery, equipment & technology, InnoPack for pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer & supplier directory at CPhI-Online.com.

 

For more information visit: www.cphi.com

The UBM EMEA annual schedule of Pharmaceutical events includes: CPhI Istanbul (8-10 March, 2017 at the IFC Istanbul Expo Center, Istanbul, Turkey); CPhI, P-MEC and Innopack South East Asia (22-24 March, 2017 at the Jakarta International Expo- Jakarta, Indonesia); CPhI Russia (28 March – 30 March, 2017 at JSC VDNH (VVC), Pavilion 75, Hall A, Moscow); CPhI, ICSE, P-MEC, BioPh and InnoPack Japan (19-21 April, 2017 at the Big Sight Exhibition Centre- Tokyo); CPhI North America and InformEx (16-18 May, 2017); CPhI China and P-MEC (20-22 June, 2017 at SNIEC, Shanghai, China); CPhI Korea (22-24 August, 2017); CPhI, ICSE, P-MEC, FDF and InnoPack Worldwide (24-26 October, 2017, Messe Frankfurt, Germany); CPhI & P-MEC India (27-30 November, 2017, BEC and BKC Exhibition and Convention Centres, Mumbai, India), Pharmapack Europe (7-8 February, 2018).

 

About UBM EMEA

UBM EMEA connects people and creates opportunities for companies across five continents to develop new business, meet customers, launch new products, promote their brands, and expand their market. Through premier brands such as TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete Show, and many others, UBM Live exhibitions, conferences, awards programs, publications, Websites, and training and certification programs are an integral part of the marketing plans of companies across more than 20 industry sectors.

 

For media enquiries, please contact:

Alex Heeley or Nadine Caillaux

De Facto Communications

T: +44 (0) 203 735 8168

E: a.heeley@defacto.com / n.caillaux@defacto.com

 

 

Subir  

Subir notas de prensa y convocatorias

Próximas convocatorias   



Ver todas

Especialidades  

Busca notas de prensa por especialidad médica o enfermedad.



Ver todas

Archivo  

Busca notas de prensa por su fecha de edición.

  Selecciona el año


Copyright © 2017, Farmavet, S.L. Todos los derechos reservados.